Abn Amro Investment Solutions Bei Gene, Ltd. Transaction History

Abn Amro Investment Solutions

  • $4.88 Trillion
  • Q3 2025

A detailed history of Abn Amro Investment Solutions transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Abn Amro Investment Solutions holds 15,197 shares of BGNE stock, worth $3.45 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
15,197
Previous 24,915 39.0%
Holding current value
$3.45 Million
Previous $6.03 Billion 14.15%
% of portfolio
0.11%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
N/A
-9,718 Reduced 39.0%
15,197 $5.18 Billion
Q2 2025

Aug 08, 2025
BUY
N/A
24,915 New
24,915 $6.03 Billion
Q1 2025

Aug 27, 2025
BUY
$175.1 - $226.71 $288,039 - $372,937
1,645 Added 6.6%
26,560 $7.23 Billion
Q4 2024

Sep 04, 2025
SELL
$174.72 - $246.04 $296,325 - $417,283
-1,696 Reduced 6.5%
24,408 $4.51 Billion
Q3 2024

Sep 04, 2025
BUY
$143.93 - $224.51 $171,132 - $266,942
1,189 Added 4.77%
26,104 $5.86 Billion
Q2 2024

Sep 04, 2025
BUY
$129.52 - $174.32 $456,428 - $614,303
3,524 Added 14.14%
28,439 $4.06 Billion
Q1 2024

Sep 05, 2025
BUY
$141.8 - $181.47 $414,056 - $529,892
2,920 Added 11.44%
28,439 $4.45 Billion
Q4 2023

Sep 05, 2025
BUY
$158.67 - $201.58 $38,239 - $48,580
241 Added 0.95%
25,519 $4.6 Billion
Q3 2023

Nov 07, 2025
BUY
$179.87 - $225.13 $1.81 Million - $2.27 Million
10,081 Added 66.34%
25,278 $4.55 Billion
Q3 2023

Nov 03, 2025
SELL
$179.87 - $225.13 $1.75 Million - $2.19 Million
-9,718 Reduced 39.0%
15,197 $5.18 Billion
Q3 2023

Sep 05, 2025
BUY
$179.87 - $225.13 $496,621 - $621,583
2,761 Added 12.26%
25,278 $4.55 Billion
Q2 2023

Sep 05, 2025
BUY
$178.3 - $266.78 $216,991 - $324,671
1,217 Added 5.71%
22,517 $4.01 Billion
Q1 2023

Sep 05, 2025
SELL
$215.53 - $274.5 $779,140 - $992,317
-3,615 Reduced 14.51%
21,300 $4.59 Billion

Others Institutions Holding BGNE

# of Institutions
296
Shares Held
30.4M
Call Options Held
147K
Put Options Held
195K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $23.5B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Abn Amro Investment Solutions Portfolio

Follow Abn Amro Investment Solutions and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

News

Stay updated on Abn Amro Investment Solutions with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email